{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:36:08Z","timestamp":1787985368897,"version":"build-2784847793"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-025-06032-w","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T09:28:25Z","timestamp":1762766905000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Myocardial infarction in rheumatic diseases"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5042-1191","authenticated-orcid":false,"given":"Yuliya","family":"Fedorchenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5942-8102","authenticated-orcid":false,"given":"Darkhan","family":"Suigenbayev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6459-398X","authenticated-orcid":false,"given":"Zhaxybek","family":"Sagtaganov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2698-8956","authenticated-orcid":false,"given":"Nurzhamal","family":"Imanbayeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3583-9442","authenticated-orcid":false,"given":"Khaiyom","family":"Mahmudzoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"issue":"9","key":"6032_CR1","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3390\/medicina59091581","volume":"59","author":"M Koo","year":"2023","unstructured":"Koo M, Lu MC (2023) Rheumatic diseases: new progress in clinical research and pathogenesis. Med (Kaunas) 59(9):1581. https:\/\/doi.org\/10.3390\/medicina59091581","journal-title":"Med (Kaunas)"},{"issue":"2","key":"6032_CR2","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.rdc.2022.02.003","volume":"48","author":"LD Ferguson","year":"2022","unstructured":"Ferguson LD, Sattar N, McInnes IB (2022) Managing cardiovascular risk in patients with rheumatic disease. Rheum Dis Clin North Am 48(2):429\u2013444. https:\/\/doi.org\/10.1016\/j.rdc.2022.02.003","journal-title":"Rheum Dis Clin North Am"},{"issue":"10","key":"6032_CR3","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1007\/s10067-023-06656-y","volume":"42","author":"O Zimba","year":"2023","unstructured":"Zimba O, Gasparyan AY (2023) Cardiovascular issues in rheumatic diseases. Clin Rheumatol 42(10):2535\u20132539. https:\/\/doi.org\/10.1007\/s10067-023-06656-y","journal-title":"Clin Rheumatol"},{"issue":"1","key":"6032_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13075-015-0552-2","volume":"17","author":"S Van Doornum","year":"2015","unstructured":"Van Doornum S, Bohensky M, Tacey MA, Brand CA, Sundararajan V, Wicks IP (2015) Increased 30-day and 1-year mortality rates and lower coronary revascularisation rates following acute myocardial infarction in patients with autoimmune rheumatic disease. Arthritis Res Ther 17(1):38. https:\/\/doi.org\/10.1186\/s13075-015-0552-2","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"6032_CR5","doi-asserted-by":"publisher","first-page":"5205","DOI":"10.1093\/rheumatology\/keab204","volume":"60","author":"A Palom\u00e4ki","year":"2021","unstructured":"Palom\u00e4ki A, Kerola AM, Malmberg M, Rautava P, Kyt\u00f6 V (2021) Patients with rheumatoid arthritis have impaired long-term outcomes after myocardial infarction: A nationwide case-control registry study. Rheumatology (Oxford) 60(11):5205\u20135215. https:\/\/doi.org\/10.1093\/rheumatology\/keab204","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"6032_CR6","doi-asserted-by":"publisher","first-page":"566","DOI":"10.2174\/1570161118666200127142936","volume":"18","author":"F Atzeni","year":"2020","unstructured":"Atzeni F, Nucera V, Gerratana E, Fiorenza A, Gianturco L, Corda M et al (2020) Cardiovascular consequences of autoimmune rheumatic diseases. Curr Vasc Pharmacol 18(6):566\u2013579. https:\/\/doi.org\/10.2174\/1570161118666200127142936","journal-title":"Curr Vasc Pharmacol"},{"issue":"5","key":"6032_CR7","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1177\/0003319720985337","volume":"72","author":"P Tornvall","year":"2021","unstructured":"Tornvall P, G\u00f6ransson A, Ekman J, J\u00e4rnbert-Pettersson H (2021) Myocardial infarction in systemic lupus erythematosus: incidence and coronary angiography findings. Angiology 72(5):459\u2013464. https:\/\/doi.org\/10.1177\/0003319720985337","journal-title":"Angiology"},{"issue":"2","key":"6032_CR8","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tcm.2016.07.006","volume":"27","author":"KP Liao","year":"2017","unstructured":"Liao KP (2017) Cardiovascular disease in patients with rheumatoid arthritis. Trends Cardiovasc Med 27(2):136\u2013140. https:\/\/doi.org\/10.1016\/j.tcm.2016.07.006","journal-title":"Trends Cardiovasc Med"},{"issue":"47","key":"6032_CR9","doi-asserted-by":"publisher","first-page":"e23009","DOI":"10.1097\/MD.0000000000023009","volume":"99","author":"X Cen","year":"2020","unstructured":"Cen X, Feng S, Wei S, Yan L, Sun L (2020) Systemic sclerosis and risk of cardiovascular disease: a PRISMA-compliant systematic review and meta-analysis of cohort studies. Med (Baltim) 99(47):e23009. https:\/\/doi.org\/10.1097\/MD.0000000000023009","journal-title":"Med (Baltim)"},{"issue":"8","key":"6032_CR10","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1093\/rheumatology\/kead464","volume":"63","author":"TH Yen","year":"2024","unstructured":"Yen TH, Chen YW, Hsieh TY, Chen YM, Huang WN, Chen YH et al (2024) The risk of major adverse cardiovascular events in patients with systemic sclerosis: a nationwide, population-based cohort study. Rheumatology (Oxford) 63(8):2074\u20132081. https:\/\/doi.org\/10.1093\/rheumatology\/kead464","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"6032_CR11","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1136\/annrheumdis-2016-210275","volume":"76","author":"O Schieir","year":"2017","unstructured":"Schieir O, Tosevski C, Glazier RH, Hogg-Johnson S, Badley EM (2017) Incident myocardial infarction associated with major types of arthritis in the general population: a systematic review and meta-analysis. Ann Rheum Dis 76(8):1396\u20131404. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210275","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"6032_CR12","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.amjms.2018.08.001","volume":"356","author":"H Li","year":"2018","unstructured":"Li H, Tong Q, Guo L et al (2018) Risk of coronary artery disease in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Am J Med Sci 356(5):451\u2013463. https:\/\/doi.org\/10.1016\/j.amjms.2018.08.001","journal-title":"Am J Med Sci"},{"key":"6032_CR13","doi-asserted-by":"publisher","unstructured":"Raj R, Thomas S, Gorantla V (2022) Accelerated atherosclerosis in rheumatoid arthritis: a systematic review. https:\/\/doi.org\/10.12688\/f1000research.112921.2. F1000Res 11:466","DOI":"10.12688\/f1000research.112921.2"},{"key":"6032_CR14","doi-asserted-by":"publisher","first-page":"5859","DOI":"10.2147\/IJGM.S490916","volume":"17","author":"S Tekeoglu","year":"2024","unstructured":"Tekeoglu S (2024) Prevalence and risk factors of cardiovascular disease in rheumatoid arthritis patients: a comparative analysis of real-world data. Int J Gen Med 17:5859\u20135868. https:\/\/doi.org\/10.2147\/IJGM.S490916","journal-title":"Int J Gen Med"},{"issue":"5","key":"6032_CR15","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.3390\/jcm14051490","volume":"14","author":"AP Hill","year":"2025","unstructured":"Hill AP, Iqbal SB, Case BC, Shankar AA, Merdler I (2025) Acute coronary syndrome and rheumatic disease. J Clin Med 14(5):1490. https:\/\/doi.org\/10.3390\/jcm14051490","journal-title":"J Clin Med"},{"issue":"13","key":"6032_CR16","doi-asserted-by":"publisher","first-page":"e018555","DOI":"10.1161\/JAHA.120.018555","volume":"10","author":"BN Weber","year":"2021","unstructured":"Weber BN, Stevens E, Barrett L, Bay C, Sinnette C, Brown JM et al (2021) Coronary microvascular dysfunction in systemic lupus erythematosus. J Am Heart Assoc 10(13):e018555. https:\/\/doi.org\/10.1161\/JAHA.120.018555","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"6032_CR17","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s00392-023-02291-4","volume":"113","author":"C Asenjo-Lobos","year":"2024","unstructured":"Asenjo-Lobos C, Gonz\u00e1lez L, Bulnes JF, Roque M, Mu\u00f1oz Venturelli P, Rodr\u00edguez GM (2024) Cardiovascular events risk in patients with systemic autoimmune diseases: a prognostic systematic review and meta-analysis. Clin Res Cardiol 113(2):246\u2013259. https:\/\/doi.org\/10.1007\/s00392-023-02291-4","journal-title":"Clin Res Cardiol"},{"key":"6032_CR18","doi-asserted-by":"publisher","first-page":"152760","DOI":"10.1016\/j.semarthrit.2025.152760","volume":"73","author":"E Ikdahl","year":"2025","unstructured":"Ikdahl E, Kerola A, Myhre PPL, Sollerud E, Semb AG (2025) Similar myocardial infarction characteristics and short-term outcomes in patients with and without inflammatory joint diseases: a nationwide Norwegian study. Semin Arthritis Rheum 73:152760","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"6032_CR19","first-page":"505","volume":"59","author":"M Iafolla","year":"2013","unstructured":"Iafolla M (2013) Rheumatoid arthritis and atypical cardiovascular disease: inflammation changing the clinical presentation. Can Fam Physician 59(5):505\u2013509","journal-title":"Can Fam Physician"},{"issue":"8","key":"6032_CR20","doi-asserted-by":"publisher","first-page":"e0289794","DOI":"10.1371\/journal.pone.0289794","volume":"18","author":"H Yaginuma","year":"2023","unstructured":"Yaginuma H, Saito Y, Sato T et al (2023) Clinical characteristics and outcomes of patients with chronic systemic inflammatory disease in acute myocardial infarction. PLoS ONE 18(8):e0289794. https:\/\/doi.org\/10.1371\/journal.pone.0289794","journal-title":"PLoS ONE"},{"issue":"7","key":"6032_CR21","doi-asserted-by":"publisher","first-page":"410","DOI":"10.4103\/singaporemedj.SMJ-2024-084","volume":"65","author":"E Tan","year":"2024","unstructured":"Tan E, Lee SSM, Poh KK, Xu C, Sia CH (2024) Electrocardiographic manifestations of cardiac disorders in rheumatological conditions. Singap Med J 65(7):410\u2013414. https:\/\/doi.org\/10.4103\/singaporemedj.SMJ-2024-084","journal-title":"Singap Med J"},{"key":"6032_CR22","doi-asserted-by":"publisher","first-page":"101161","DOI":"10.1016\/j.ijcha.2022.101161","volume":"44","author":"D Aiewruengsurat","year":"2022","unstructured":"Aiewruengsurat D, Phongnarudech T, Liabsuetrakul T, Nilmoje T (2022) Correlation of rheumatoid and cardiac biomarkers with cardiac anatomy and function in rheumatoid arthritis patients without clinically overt cardiovascular diseases: a cross-sectional study. Int J Cardiol Heart Vasc 44:101161. https:\/\/doi.org\/10.1016\/j.ijcha.2022.101161","journal-title":"Int J Cardiol Heart Vasc"},{"key":"6032_CR23","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409. https:\/\/doi.org\/10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"},{"key":"6032_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2024.07.016","volume":"128","author":"AA Drosos","year":"2024","unstructured":"Drosos AA, Venetsanopoulou AA, Pelechas E, Voulgari PV (2024) Exploring cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Eur J Intern Med 128:1\u20139. https:\/\/doi.org\/10.1016\/j.ejim.2024.07.016","journal-title":"Eur J Intern Med"},{"issue":"9","key":"6032_CR25","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.3390\/medicina59091550","volume":"59","author":"D Bedekovi\u0107","year":"2023","unstructured":"Bedekovi\u0107 D, Bo\u0161njak I, \u0160ari\u0107 S, Kirner D, Novak S (2023) Role of inflammatory cytokines in rheumatoid arthritis and development of atherosclerosis: a review. Med (Kaunas) 59(9):1550. https:\/\/doi.org\/10.3390\/medicina59091550","journal-title":"Med (Kaunas)"},{"issue":"6","key":"6032_CR26","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00109-025-02539-8","volume":"103","author":"ASA Husaini","year":"2025","unstructured":"Husaini ASA, Fathima A, Halawa D et al (2025) Exploring endothelial dysfunction in major rheumatic diseases: current trends and future directions. J Mol Med (Berl) 103(6):635\u2013649. https:\/\/doi.org\/10.1007\/s00109-025-02539-8","journal-title":"J Mol Med (Berl)"},{"issue":"21","key":"6032_CR27","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.3390\/nu15214584","volume":"15","author":"B Chen","year":"2023","unstructured":"Chen B, Wang Y, Chen G (2023) New potentiality of bioactive substances: regulating the NLRP3 inflammasome in autoimmune diseases. Nutrients 15(21):4584. https:\/\/doi.org\/10.3390\/nu15214584","journal-title":"Nutrients"},{"issue":"1","key":"6032_CR28","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12964-025-02331-8","volume":"23","author":"L Cai","year":"2025","unstructured":"Cai L, Zhang K, Gao J et al (2025) ACPA-induced ATP release and K\u207a efflux trigger NLRP3 inflammasome activation in rheumatoid arthritis. Cell Commun Signal 23(1):302. https:\/\/doi.org\/10.1186\/s12964-025-02331-8","journal-title":"Cell Commun Signal"},{"issue":"10","key":"6032_CR29","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1007\/s00296-024-05659-5","volume":"44","author":"HJ Hinkema","year":"2024","unstructured":"Hinkema HJ, Westra J, Arends S, Brouwer E, Mulder DJ (2024) Higher levels of markers for early atherosclerosis in anti-citrullinated protein antibody positive individuals at risk for RA: a cross-sectional study. Rheumatol Int 44(10):2007\u20132016. https:\/\/doi.org\/10.1007\/s00296-024-05659-5","journal-title":"Rheumatol Int"},{"issue":"1","key":"6032_CR30","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10238-024-01406-z","volume":"24","author":"S Chen","year":"2024","unstructured":"Chen S, Zhou Y, Wang C, Jiang H, Zhao Y, Zhao J et al (2024) Impact of antiphospholipid antibodies on cardiac valve lesions in systemic lupus erythematosus: a systematic review and meta-analysis. Clin Exp Med 24(1):147. https:\/\/doi.org\/10.1007\/s10238-024-01406-z","journal-title":"Clin Exp Med"},{"issue":"3","key":"6032_CR31","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3390\/biomedicines12030530","volume":"12","author":"N Nagy","year":"2024","unstructured":"Nagy N, B\u00f3i B, Papp G, Fi\u00e1k E, G\u00e1sp\u00e1r-Kiss E, Perge B et al (2024) Antiphospholipid antibodies are major risk factors for non-thrombotic cardiac complications in systemic lupus erythematosus. Biomedicines 12(3):530. https:\/\/doi.org\/10.3390\/biomedicines12030530","journal-title":"Biomedicines"},{"issue":"3","key":"6032_CR32","doi-asserted-by":"publisher","first-page":"e12440","DOI":"10.1111\/micc.12440","volume":"26","author":"D Saygin","year":"2019","unstructured":"Saygin D, Highland KB, Tonelli AR (2019) Microvascular involvement in systemic sclerosis and systemic lupus erythematosus. Microcirculation 26(3):e12440. https:\/\/doi.org\/10.1111\/micc.12440","journal-title":"Microcirculation"},{"issue":"1","key":"6032_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11886-024-02164-w","volume":"27","author":"R Osgueritchian","year":"2025","unstructured":"Osgueritchian R, Mombeini H, Jani VP, Hsu S, Hummers LK, Wigley FM et al (2025) Myocardial disease in systemic sclerosis: recent updates and clinical implications. Curr Cardiol Rep 27(1):3. https:\/\/doi.org\/10.1007\/s11886-024-02164-w","journal-title":"Curr Cardiol Rep"},{"issue":"3","key":"6032_CR34","doi-asserted-by":"publisher","first-page":"347","DOI":"10.33549\/physiolres.935575","volume":"74","author":"M Jalali","year":"2025","unstructured":"Jalali M, \u0160tevl\u00edk J, Jalali Y, Ga\u017eov\u00e1 A, Kyselovi\u010d J, Killinger Z et al (2025) Myocardial fibrosis, the silent instigator of diastolic dysfunction in patients with rheumatoid arthritis. Physiol Res 74(3):347\u2013358. https:\/\/doi.org\/10.33549\/physiolres.935575","journal-title":"Physiol Res"},{"key":"6032_CR35","doi-asserted-by":"publisher","first-page":"1607018","DOI":"10.3389\/fcvm.2025.1607018","volume":"12","author":"Z Tarjanyi","year":"2025","unstructured":"Tarjanyi Z, Szabo L, Mong N, Mahmood A, Dohy Z, Drobni ZD et al (2025) Subclinical myocardial changes in rheumatoid arthritis: cardiovascular magnetic resonance evidence of immuno-inflammatory remodeling. Front Cardiovasc Med 12:1607018. https:\/\/doi.org\/10.3389\/fcvm.2025.1607018","journal-title":"Front Cardiovasc Med"},{"issue":"22","key":"6032_CR36","doi-asserted-by":"publisher","first-page":"6812","DOI":"10.3390\/jcm11226812","volume":"11","author":"S Kang","year":"2022","unstructured":"Kang S, Han K, Jung JH, Eun Y, Kim IY, Hwang J et al (2022) Associations between cardiovascular outcomes and rheumatoid arthritis: a nationwide population-based cohort study. J Clin Med 11(22):6812. https:\/\/doi.org\/10.3390\/jcm11226812","journal-title":"J Clin Med"},{"issue":"2","key":"6032_CR37","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.semarthrit.2021.03.003","volume":"51","author":"K Yazdani","year":"2021","unstructured":"Yazdani K, Xie H, Avina-Zubieta JA, Zheng Y, Abrahamowicz M, Lacaille D (2021) Has the excess risk of acute myocardial infarction in rheumatoid arthritis relative to the general population declined? A population study of trends over time. Semin Arthritis Rheum 51(2):442\u2013449. https:\/\/doi.org\/10.1016\/j.semarthrit.2021.03.003","journal-title":"Semin Arthritis Rheum"},{"issue":"14","key":"6032_CR38","doi-asserted-by":"publisher","first-page":"e19658","DOI":"10.1097\/MD.0000000000019658","volume":"99","author":"H Wang","year":"2020","unstructured":"Wang H, Li X, Gong G (2020) Cardiovascular outcomes in patients with co-existing coronary artery disease and rheumatoid arthritis: a systematic review and meta-analysis. Med (Baltim) 99(14):e19658. https:\/\/doi.org\/10.1097\/MD.0000000000019658","journal-title":"Med (Baltim)"},{"key":"6032_CR39","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jocn.2020.06.002","volume":"78","author":"JK Lee","year":"2020","unstructured":"Lee JK, Kim H, Hong JB, Sheen SH, Han IB, Sohn S (2020) Association of acute myocardial infarction with seropositive rheumatoid arthritis in korea: a nationwide longitudinal cohort study. J Clin Neurosci 78:97\u2013101. https:\/\/doi.org\/10.1016\/j.jocn.2020.06.002","journal-title":"J Clin Neurosci"},{"issue":"1","key":"6032_CR40","doi-asserted-by":"publisher","first-page":"e001113","DOI":"10.1136\/rmdopen-2019-001113","volume":"6","author":"A de Thurah","year":"2020","unstructured":"de Thurah A, Andersen IT, Tinggaard AB et al (2020) Risk of major adverse cardiovascular events among patients with rheumatoid arthritis after initial CT-based diagnosis and treatment. RMD Open 6(1):e001113. https:\/\/doi.org\/10.1136\/rmdopen-2019-001113","journal-title":"RMD Open"},{"key":"6032_CR41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.amjcard.2020.10.048","volume":"140","author":"LP Dawson","year":"2021","unstructured":"Dawson LP, Dinh D, O\u2019Brien J, Duffy SJ, Guymer E, Brennan A et al (2021) Outcomes of percutaneous coronary intervention in patients with rheumatoid arthritis. Am J Cardiol 140:39\u201346. https:\/\/doi.org\/10.1016\/j.amjcard.2020.10.048","journal-title":"Am J Cardiol"},{"key":"6032_CR42","doi-asserted-by":"publisher","first-page":"1099861","DOI":"10.3389\/fcvm.2023.1099861","volume":"10","author":"M Wang","year":"2023","unstructured":"Wang M, Chao C, Mei K, Di D, Qian Y, Wang B et al (2023) Relationship between rheumatoid arthritis and cardiovascular comorbidity, causation or co-occurrence: a Mendelian randomization study. Front Cardiovasc Med 10:1099861. https:\/\/doi.org\/10.3389\/fcvm.2023.1099861","journal-title":"Front Cardiovasc Med"},{"key":"6032_CR43","doi-asserted-by":"publisher","first-page":"1017444","DOI":"10.3389\/fimmu.2022.1017444","volume":"13","author":"HY Guo","year":"2022","unstructured":"Guo HY, Wang W, Peng H, Yuan H (2022) Bidirectional two-sample Mendelian randomization study of causality between rheumatoid arthritis and myocardial infarction. Front Immunol 13:1017444. https:\/\/doi.org\/10.3389\/fimmu.2022.1017444","journal-title":"Front Immunol"},{"issue":"2","key":"6032_CR44","doi-asserted-by":"publisher","first-page":"e002411","DOI":"10.1136\/rmdopen-2022-002411","volume":"8","author":"GA Karpouzas","year":"2022","unstructured":"Karpouzas GA, Papotti B, Ormseth S, Palumbo M, Hernandez E, Adorni MP et al (2022) Serum cholesterol loading capacity on macrophages is linked to coronary atherosclerosis and cardiovascular event risk in rheumatoid arthritis. RMD Open 8(2):e002411. https:\/\/doi.org\/10.1136\/rmdopen-2022-002411","journal-title":"RMD Open"},{"issue":"7","key":"6032_CR45","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3899\/jrheum.2024-1036","volume":"52","author":"JA Singh","year":"2025","unstructured":"Singh JA, Chandrupatla SR (2025) Rural-dwelling patients with rheumatoid arthritis and risk of myocardial infarction hospitalization: an observational study using the National inpatient sample. J Rheumatol 52(7):655\u2013661. https:\/\/doi.org\/10.3899\/jrheum.2024-1036","journal-title":"J Rheumatol"},{"issue":"11","key":"6032_CR46","doi-asserted-by":"publisher","first-page":"e6402","DOI":"10.1002\/ccr3.6402","volume":"10","author":"S Kaewnamchai","year":"2022","unstructured":"Kaewnamchai S, Temnithikul B, Ruchakorn N, Angkananard T (2022) A challenging case of rheumatoid arthritis-associated aortitis presenting with erythema nodosum after ST-segment elevation myocardial infarction: a case report. Clin Case Rep 10(11):e6402. https:\/\/doi.org\/10.1002\/ccr3.6402","journal-title":"Clin Case Rep"},{"key":"6032_CR47","doi-asserted-by":"publisher","first-page":"882911","DOI":"10.3389\/fmed.2022.882911","volume":"9","author":"CM Chang","year":"2022","unstructured":"Chang CM, Lin JR, Fu TC (2022) Associations between sarcopenia, heart failure and myocardial infarction in patients with systemic lupus erythematosus and rheumatoid arthritis. Front Med (Lausanne) 9:882911. https:\/\/doi.org\/10.3389\/fmed.2022.882911","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"6032_CR48","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/acr.24850","volume":"75","author":"A Jorge","year":"2023","unstructured":"Jorge A, Lu N, Choi H, Esdaile JM, Lacaille D, Avina-Zubieta JA (2023) Hydroxychloroquine use and cardiovascular events among patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Care Res (Hoboken) 75(4):743\u2013748. https:\/\/doi.org\/10.1002\/acr.24850","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"6032_CR49","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/acr.24214","volume":"73","author":"M Holmqvist","year":"2021","unstructured":"Holmqvist M, Mantel \u00c4, W\u00e5llberg-Jonsson S, James S, Jernberg T, Askling J (2021) Findings on coronary angiographies in patients with rheumatoid arthritis and ischemic heart disease: are they different from patients without rheumatoid arthritis? Arthritis Care Res (Hoboken) 73(5):658\u2013665. https:\/\/doi.org\/10.1002\/acr.24214","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"6032_CR50","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1177\/09612033221147471","volume":"32","author":"N Bello","year":"2023","unstructured":"Bello N, Meyers KJ, Workman J, Hartley L, McMahon M (2023) Cardiovascular events and risk in patients with systemic lupus erythematosus: systematic literature review and meta-analysis. Lupus 32(3):325\u2013341. https:\/\/doi.org\/10.1177\/09612033221147471","journal-title":"Lupus"},{"issue":"5","key":"6032_CR51","doi-asserted-by":"publisher","first-page":"e39284","DOI":"10.7759\/cureus.39284","volume":"15","author":"MA Nor","year":"2023","unstructured":"Nor MA, Ogedegbe OJ, Barbarawi A, Ali AI, Sheikh IM, Yussuf FM et al (2023) Systemic lupus erythematosus and cardiovascular diseases: a systematic review. Cureus 15(5):e39284. https:\/\/doi.org\/10.7759\/cureus.39284","journal-title":"Cureus"},{"issue":"3","key":"6032_CR52","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00281-022-00922-y","volume":"44","author":"CB Oliveira","year":"2022","unstructured":"Oliveira CB, Kaplan MJ (2022) Cardiovascular disease risk and pathogenesis in systemic lupus erythematosus. Semin Immunopathol 44(3):309\u2013324. https:\/\/doi.org\/10.1007\/s00281-022-00922-y","journal-title":"Semin Immunopathol"},{"issue":"2","key":"6032_CR53","doi-asserted-by":"publisher","first-page":"e001247","DOI":"10.1136\/rmdopen-2020-001247","volume":"6","author":"J Yazdany","year":"2020","unstructured":"Yazdany J, Pooley N, Langham J, Nicholson L, Langham S, Embleton N et al (2020) Systemic lupus erythematosus, stroke and myocardial infarction risk: a systematic review and meta-analysis. RMD Open 6(2):e001247. https:\/\/doi.org\/10.1136\/rmdopen-2020-001247","journal-title":"RMD Open"},{"issue":"1","key":"6032_CR54","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1159\/000546177","volume":"5","author":"M Vakhshoori","year":"2025","unstructured":"Vakhshoori M, Heidari-Bateni G, Mathew RO, Abdipour A, Daher NS, Hiremath S et al (2025) Cardiovascular events in lupus nephritis: a systematic review and meta-analysis. Glomerular Dis 5(1):261\u2013277. https:\/\/doi.org\/10.1159\/000546177","journal-title":"Glomerular Dis"},{"key":"6032_CR55","doi-asserted-by":"publisher","first-page":"107466","DOI":"10.1016\/j.intimp.2021.107466","volume":"94","author":"X Lu","year":"2021","unstructured":"Lu X, Wang Y, Zhang J, Pu D, Hu N, Luo J et al (2021) Patients with systemic lupus erythematosus face a high risk of cardiovascular disease: a systematic review and meta-analysis. Int Immunopharmacol 94:107466. https:\/\/doi.org\/10.1016\/j.intimp.2021.107466","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"6032_CR56","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1080\/08820139.2019.1567534","volume":"48","author":"MM Gu","year":"2019","unstructured":"Gu MM, Wang XP, Cheng QY, Zhao YL, Zhang TP, Li BZ et al (2019) A meta-analysis of cardiovascular events in systemic lupus erythematosus. Immunol Invest 48(5):505\u2013520. https:\/\/doi.org\/10.1080\/08820139.2019.1567534","journal-title":"Immunol Invest"},{"issue":"10","key":"6032_CR57","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1007\/s10067-023-06655-z","volume":"42","author":"R Hintenberger","year":"2023","unstructured":"Hintenberger R, Affenzeller B, Vladychuk V, Pieringer H (2023) Cardiovascular risk in axial spondyloarthritis: a systematic review. Clin Rheumatol 42(10):2621\u20132633. https:\/\/doi.org\/10.1007\/s10067-023-06655-z","journal-title":"Clin Rheumatol"},{"issue":"4","key":"6032_CR58","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/1756-185X.13970","volume":"24","author":"JH Kim","year":"2021","unstructured":"Kim JH, Choi IA (2021) Cardiovascular morbidity and mortality in patients with spondyloarthritis: a meta-analysis. Int J Rheum Dis 24(4):477\u2013486. https:\/\/doi.org\/10.1111\/1756-185X.13970","journal-title":"Int J Rheum Dis"},{"issue":"6","key":"6032_CR59","doi-asserted-by":"publisher","first-page":"e86284","DOI":"10.7759\/cureus.86284","volume":"17","author":"MAM Khan","year":"2025","unstructured":"Khan MAM, Siddiqui TW, Siddiqui RW et al (2025) Shared mechanisms between osteoarthritis and cardiovascular disease: a clinical and pathophysiological review. Cureus 17(6):e86284. https:\/\/doi.org\/10.7759\/cureus.86284","journal-title":"Cureus"},{"issue":"6","key":"6032_CR60","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jbspin.2019.06.013","volume":"86","author":"S Mathieu","year":"2019","unstructured":"Mathieu S, Couderc M, Tournadre A, Soubrier M (2019) Cardiovascular profile in osteoarthritis: a meta-analysis of cardiovascular events and risk factors. Joint Bone Spine 86(6):679\u2013684. https:\/\/doi.org\/10.1016\/j.jbspin.2019.06.013","journal-title":"Joint Bone Spine"},{"issue":"4","key":"6032_CR61","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/FJC.0000000000001603","volume":"84","author":"BY Hsiao","year":"2024","unstructured":"Hsiao BY (2024) Sj\u00f6gren syndrome and outcomes of acute myocardial infarction: a propensity score-matched analysis of the nationwide inpatient sample 2005\u20132018. J Cardiovasc Pharmacol 84(4):394\u2013399. https:\/\/doi.org\/10.1097\/FJC.0000000000001603","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"6032_CR62","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.mayocp.2020.04.044","volume":"96","author":"MO Mohamed","year":"2021","unstructured":"Mohamed MO, Roddy E, Ya\u2019qoub L, Myint PK, Al Alasnag M, Alraies C et al (2021) Acute myocardial infarction in autoimmune rheumatologic disease: a nationwide analysis of clinical outcomes and predictors of management strategy. Mayo Clin Proc 96(2):388\u2013399. https:\/\/doi.org\/10.1016\/j.mayocp.2020.04.044","journal-title":"Mayo Clin Proc"},{"key":"6032_CR63","doi-asserted-by":"publisher","first-page":"726044","DOI":"10.3389\/fphar.2021.726044","volume":"12","author":"SF Liu","year":"2021","unstructured":"Liu SF, Lee CK, Huang KC, Lin LY, Hsieh MY, Lin TT (2021) Long-term effect of non-selective beta-blockers in patients with rheumatoid arthritis after myocardial infarction: a nationwide cohort study. Front Pharmacol 12:726044. https:\/\/doi.org\/10.3389\/fphar.2021.726044","journal-title":"Front Pharmacol"},{"issue":"1","key":"6032_CR64","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1136\/ard-2022-222259","volume":"82","author":"C Charles-Schoeman","year":"2023","unstructured":"Charles-Schoeman C, Buch MH, Dougados M, Bhatt DL, Giles JT, Ytterberg SR et al (2023) Risk of major adverse cardiovascular events with Tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL surveillance. Ann Rheum Dis 82(1):119\u2013129. https:\/\/doi.org\/10.1136\/ard-2022-222259","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"6032_CR65","doi-asserted-by":"publisher","first-page":"e26430","DOI":"10.7759\/cureus.26430","volume":"14","author":"S Nair","year":"2022","unstructured":"Nair S, Singh Kahlon S, Sikandar R, Peddemul A, Tejovath S, Hassan D et al (2022) Tumor necrosis factor-alpha inhibitors and cardiovascular risk in rheumatoid arthritis: a systematic review. Cureus 14(6):e26430. https:\/\/doi.org\/10.7759\/cureus.26430","journal-title":"Cureus"},{"issue":"2","key":"6032_CR66","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10557-022-07387-z","volume":"38","author":"A Cordova Sanchez","year":"2024","unstructured":"Cordova Sanchez A, Khokhar F, Olonoff DA, Carhart RL (2024) Hydroxychloroquine and cardiovascular events in patients with rheumatoid arthritis. Cardiovasc Drugs Ther 38(2):297\u2013304. https:\/\/doi.org\/10.1007\/s10557-022-07387-z","journal-title":"Cardiovasc Drugs Ther"},{"key":"6032_CR67","doi-asserted-by":"publisher","unstructured":"Skielta M, S\u00f6derstr\u00f6m L, Rantap\u00e4\u00e4-Dahlqvist S, S\u00f6dergren A, Mooe T (2025) Is there an association between anti-inflammatory medical treatments for rheumatoid arthritis and mortality after first myocardial infarction? Scand J Rheumatol Published online August 29, 2025. https:\/\/doi.org\/10.1080\/03009742.2025.2544409","DOI":"10.1080\/03009742.2025.2544409"},{"issue":"2","key":"6032_CR68","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4078\/jrd.2024.0104","volume":"32","author":"SM Ahn","year":"2025","unstructured":"Ahn SM, Kim S, Kim YJ, Hong S, Lee CK, Yoo B et al (2025) Risk of acute myocardial infarction associated with anti-rheumatic agents in patients with rheumatoid arthritis: a nationwide population-based case-control study. J Rheum Dis 32(2):113\u2013121. https:\/\/doi.org\/10.4078\/jrd.2024.0104","journal-title":"J Rheum Dis"},{"issue":"12","key":"6032_CR69","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1136\/annrheumdis-2021-220577","volume":"80","author":"AJ Ocon","year":"2021","unstructured":"Ocon AJ, Reed G, Pappas DA, Curtis JR, Kremer JM (2021) Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis. Ann Rheum Dis 80(12):1522\u20131529. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220577","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"6032_CR70","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.cgh.2023.09.033","volume":"22","author":"SS Mattay","year":"2024","unstructured":"Mattay SS, Zamani M, Saturno D, Loftus EV Jr, Ciorba MA, Yarur A et al (2024) Risk of major adverse cardiovascular events in immune-mediated inflammatory disorders on biologics and small molecules: network meta-analysis. Clin Gastroenterol Hepatol 22(5):961\u2013970e12. https:\/\/doi.org\/10.1016\/j.cgh.2023.09.033","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"6032_CR71","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ihj.2024.12.002","volume":"77","author":"S Piplani","year":"2025","unstructured":"Piplani S, Kostojchin A, Kong S, Sharma A, Brown D, Jelic V et al (2025) Percutaneous coronary intervention (PCI) in patients with rheumatoid arthritis: a systematic review and meta-analysis. Indian Heart J 77(1):7\u201313. https:\/\/doi.org\/10.1016\/j.ihj.2024.12.002","journal-title":"Indian Heart J"},{"issue":"37","key":"6032_CR72","doi-asserted-by":"publisher","first-page":"e44458","DOI":"10.1097\/MD.0000000000044458","volume":"104","author":"S Khadka","year":"2025","unstructured":"Khadka S, Timilsina B, Ammembal A, Chowdhury F, Suwal K, Shrestha B et al (2025) Short-term and long-term outcomes in rheumatoid arthritis patients following percutaneous coronary intervention: a systematic review and meta-analysis. Med (Baltim) 104(37):e44458. https:\/\/doi.org\/10.1097\/MD.0000000000044458","journal-title":"Med (Baltim)"},{"issue":"8","key":"6032_CR73","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1177\/2048872616649860","volume":"6","author":"K Nochioka","year":"2017","unstructured":"Nochioka K, Biering-S\u00f8rensen T, Hansen KW, S\u00f8rensen R, Pedersen S, J\u00f8rgensen PG et al (2017) Long-term outcomes in patients with rheumatologic disorders undergoing percutaneous coronary intervention: a BAsel stent Kosten-Effektivit\u00e4ts Trial\u2013PROspective validation examination (BASKET-PROVE) sub-study. Eur Heart J Acute Cardiovasc Care 6(8):778\u2013786. https:\/\/doi.org\/10.1177\/2048872616649860","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"9","key":"6032_CR74","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1093\/rheumatology\/kez639","volume":"59","author":"SC Martinez","year":"2020","unstructured":"Martinez SC, Mohamed M, Potts J, Abhishek A, Roddy E, Savage M et al (2020) Percutaneous coronary intervention outcomes in patients with rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis. Rheumatology (Oxford) 59(9):2512\u20132522. https:\/\/doi.org\/10.1093\/rheumatology\/kez639","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"6032_CR75","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.amjmed.2020.02.039","volume":"133","author":"A Elbadawi","year":"2020","unstructured":"Elbadawi A, Ahmed HMA, Elgendy IY, Omer MA, Ogunbayo GO, Abohamad S et al (2020) Outcomes of acute myocardial infarction in patients with rheumatoid arthritis. Am J Med 133(10):1168\u20131179e4. https:\/\/doi.org\/10.1016\/j.amjmed.2020.02.039","journal-title":"Am J Med"},{"issue":"1","key":"6032_CR76","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1080\/07853890.2021.1969591","volume":"53","author":"M Malmberg","year":"2021","unstructured":"Malmberg M, Palom\u00e4ki A, Sipil\u00e4 JOT, Rautava P, Gunn J, Kyt\u00f6 V (2021) Long-term outcomes after coronary artery bypass surgery in patients with rheumatoid arthritis. Ann Med 53(1):1512\u20131519. https:\/\/doi.org\/10.1080\/07853890.2021.1969591","journal-title":"Ann Med"},{"key":"6032_CR77","doi-asserted-by":"publisher","first-page":"1759720X2513571","DOI":"10.1177\/1759720X251357188","volume":"17","author":"T Ruiz Maya","year":"2025","unstructured":"Ruiz Maya T, Ciosek A, Frech T, Maldonado G, Myers K, Chew E, Baba J, Donato A, Gupta D, Ross L (2025) Cardio-rheumatology: integrated care and the opportunities for personalized medicine. Ther Adv Musculoskelet Dis 17:1759720X251357188. https:\/\/doi.org\/10.1177\/1759720X251357188","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"1","key":"6032_CR78","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s41927-024-00378-7","volume":"8","author":"JK Karstensen","year":"2024","unstructured":"Karstensen JK, Bremander A, Christensen JR, Primdahl J (2024) Participation in cardiovascular screening consultations: the who, when and why \u2013 a cohort study on patients with rheumatoid arthritis. BMC Rheumatol 8(1):8. https:\/\/doi.org\/10.1186\/s41927-024-00378-7","journal-title":"BMC Rheumatol"},{"issue":"12","key":"6032_CR79","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1007\/s10067-022-06335-4","volume":"41","author":"JD Guerra","year":"2022","unstructured":"Guerra JD, De Santiago AB, Reed S, Hammonds KP, Shaver C, Widmer RJ, Scholz BA (2022) Cardiology co-management of rheumatoid arthritis patients with coronary artery disease as an intervention reduces hospitalization rates and adverse event occurrence. Clin Rheumatol 41(12):3715\u20133724. https:\/\/doi.org\/10.1007\/s10067-022-06335-4","journal-title":"Clin Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-06032-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-025-06032-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-06032-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T06:40:48Z","timestamp":1765348848000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-025-06032-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":79,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6032"],"URL":"https:\/\/doi.org\/10.1007\/s00296-025-06032-w","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"270"}}